Continue with FacebookLooking to list your PhD opportunities? Log in here.
Prof Rob Falconer,
Dr Steven Shnyder
Applications accepted all year round
Self-Funded PhD Students Only
About the Project
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases. Polysialic acid is aberrantly re-expressed on the surface of many tumours, where it plays a key role in diseases progression and metastasis. It is therefore an attractive anti-cancer target (see Current Cancer Drug Targets, 2012, 12, 925-939).
The ICT is focused on the development of novel polysialyltransferase inhibitors, using computational chemistry to aid compound design. We have developed assays to assess compound inhibition (see Analyst, 2016, 141, 5849-5856) and have utilized tool compounds to show the potential of the approach (see PLoS ONE, 2013, 8, e73366). We additionally have explored the role of polySia expression in hypoxia, a characteristic common to solid tumours (see Scientific Reports, 2016, 6, 33026; ChemBioChem, 2017, 18, 1332-1337). The wider project benefits from funding from programme funding from Yorkshire Cancer Research and more recently from the Wellcome Trust. The student will join a successful, motivated multidisciplinary team with expertise in medicinal chemistry, pharmacology, immunohistochemistry and drug analysis.
This project will focus on the biological evaluation of potential polysialyltransferase inhibitors, utilising in vitro assays to assess compound inhibition, and techniques to assess effects of compounds on cell adhesion, migration, and invasion.
The ICT is focused on the development of novel polysialyltransferase inhibitors, using computational chemistry to aid compound design. We have developed assays to assess compound inhibition (see Analyst, 2016, 141, 5849-5856) and have utilized tool compounds to show the potential of the approach (see PLoS ONE, 2013, 8, e73366). We additionally have explored the role of polySia expression in hypoxia, a characteristic common to solid tumours (see Scientific Reports, 2016, 6, 33026; ChemBioChem, 2017, 18, 1332-1337). The wider project benefits from funding from programme funding from Yorkshire Cancer Research and more recently from the Wellcome Trust. The student will join a successful, motivated multidisciplinary team with expertise in medicinal chemistry, pharmacology, immunohistochemistry and drug analysis.
This project will focus on the biological evaluation of potential polysialyltransferase inhibitors, utilising in vitro assays to assess compound inhibition, and techniques to assess effects of compounds on cell adhesion, migration, and invasion.
Funding Notes
This is a self-funded project; applicants will be expected to pay their own fees or have access to suitable third-party funding. In addition to the university's standard tuition fees, bench fees of £10,000 per year also apply to this project.
References
Entry requirements
At least 2:1 honours degree in a pharmacy, biochemistry or pharmacology-related subject. An MSc in any of these areas is an advantage.
For full details of our entry requirements, please visit our website.
At least 2:1 honours degree in a pharmacy, biochemistry or pharmacology-related subject. An MSc in any of these areas is an advantage.
For full details of our entry requirements, please visit our website.
Email Now
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
Why not add a message here
* required field
The information you submit to University of Bradford will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in Bradford, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs
PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Developing new treatment combinations to target dormant cancer cells in myeloma
University of Sheffield
Deciphering key steps in the metastatic process of breast cancer by focusing on the role of MAFF
University of Oxford
Regulation of apoptosis-induced compensatory cell proliferation and its implications for cancer and tissue regeneration
University of Birmingham